Emisphere Technologies Inc (EMIS)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

240 CEDAR KNOLLS RD. CEDAR KNOLLS, NJ 07927

Emisphere Tech focuses on the oral delivery of medicines, which, for a variety of reasons, cannot be offered to patients directly in an oral form. This biopharmaceutical company has several product candidates in preclinical and clinical development across a range of therapeutic areas.

Data as of 2019-12-02 13:22:35 -0500
Market Cap303.651 Million Shares Outstanding60.852 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-0.04
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low11.23 / 1.93 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from EMIS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding EMIS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EMIS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RACHESKY MARK H MD

MHR CAPITAL PARTNERS MASTER ACCOUNT LP

MHR ADVISORS LLC

MHR INSTITUTIONAL PARTNERS II LP

MHR INSTITUTIONAL PARTNERS IIA LP

MHR INSTITUTIONAL ADVISORS II LLC

MHRC LLC

MHRC II LLC

MHR FUND MANAGEMENT LLC

MHR HOLDINGS LLC

  • Director
  • 10% Owner
0 2017-06-30 0

RACHESKY MARK H MD

  • Director
  • 10% Owner
0 2017-05-18 0

WEISER MICHAEL

  • Director
0 2017-05-18 0

HARKEY JOHN D JR

  • Director
0 2017-05-18 0

ROTHWELL TIMOTHY G

  • Director
0 2017-05-18 0

MCINERNEY TIMOTHY

  • Director
0 2017-05-18 0

PLOTSKER JACOB M

  • Director
0 2017-05-18 0

RUBINO ALAN L CEO

  • Officer
0 2017-01-24 0

GALLANTAR ALAN V INTERIM CFO

  • Officer
0 2016-06-22 0

GARONE MICHAEL CFO

  • Officer
0 2016-01-14 0

RACHESKY MARK H MD

MHR CAPITAL PARTNERS MASTER ACCOUNT LP

MHR ADVISORS LLC

MHR INSTITUTIONAL PARTNERS II LP

MHR INSTITUTIONAL PARTNERS IIA LP

MHR INSTITUTIONAL ADVISORS II LLC

MHR FUND MANAGEMENT LLC

MHR HOLDINGS LLC

  • Director
  • 10% Owner
0 2012-12-31 0

MHRC LLC

  • 10% Owner
7,073,179 2012-12-31 0

MHRC II LLC

  • 10% Owner
11,405,186 2012-12-31 0

RILEY GARY SEE REMARKS

  • Officer
0 2012-05-31 0

RACHESKY MARK H MD

MHR CAPITAL PARTNERS MASTER ACCOUNT LP

MHR ADVISORS LLC

MHR INSTITUTIONAL PARTNERS II LP

MHR INSTITUTIONAL PARTNERS IIA LP

MHR INSTITUTIONAL ADVISORS II LLC

MHR FUND MANAGEMENT LLC

  • Director
  • 10% Owner
0 2011-12-31 0

MHR INSTITUTIONAL PARTNERS II LP

MHR FUND MANAGEMENT LLC

MHR INSTITUTIONAL ADVISORS II LLC

RACHESKY MARK H MD

  • Director
  • 10% Owner
2,412,718 2010-08-26 0

RACHESKY MARK H MD

MHR CAPITAL PARTNERS MASTER ACCOUNT LP

MHR ADVISORS LLC

MHR INSTITUTIONAL PARTNERS IIA LP

MHR INSTITUTIONAL ADVISORS II LLC

MHR FUND MANAGEMENT LLC

  • Director
  • 10% Owner
0 2010-06-30 0

NOVINSKI MICHAEL V CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2010-03-10 0

MOCH KENNETH I

  • Director
0 2009-05-15 0

BERGER FRANKLIN M

  • Director
0 2009-05-15 0

PACK HOWARD M

  • Director
101,470 2008-08-13 0

CARTER STEPHEN K

  • Director
11,107 2008-08-13 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments